Effect of metabolic acidosis on the potassium content of bone.
Metabolic acidosis induces resorption of cultured bone, resulting in a net efflux of calcium (Ca) from the bone and an apparent loss of mineral potassium (K). However, in these organ cultures, there is diffusion of K between the medium and the crystal lattice, causing difficulty in interpretation of the acid-induced changes in mineral ion composition. To determine the effects of acidosis on bone mineral K, we injected 4-day-old neonatal mice with pure stable isotope 41K, equal to approximately 5% of their total body K. Calvariae were dissected 24 h later and then cultured for 24 h in medium without added 41K, either at pH approximately 7.4 (Ctl) or at pH approximately 7.1 (Ac), with or without the osteoclastic inhibitor calcitonin (3 x 10(-9) M, CT). The bone isotopic ion content was determined with a high-resolution scanning ion microprobe utilizing secondary ion mass spectrometry. 41K is present in nature at 6.7% of total K. The injected 41K raised the ratio of bone 41K/(39K+41K) to 9.8+/-0.5% on the surface (ratios of counts per second of detected secondary ions, mean+/-95% confidence interval) but did not alter the ratio in the interior (6.9+/-0.4%), indicating biological incorporation of the 41K into the mineral surface. The ratios of 41K/40Ca on the surface of Ctl calvariae was 14.4+/-1.2, indicating that bone mineral surface is rich in K compared with Ca. Compared with Ctl, Ac caused a marked increase in the net Ca efflux from bone that was blocked by CT. Ac also induced a marked fall in the ratio of 41K/40Ca on the surface of the calvariae (43+/-0.5, p < 0.01 vs. Ctl), which was partially blocked by CT (8.2+/-0.9, p < 0.01 vs. Ctl and vs. Ac), indicating that Ac causes a greater release of bone mineral K than Ca which is partially blocked by CT. Thus, bone mineral surface is rich in K relative to Ca, acidosis induces a greater release of surface mineral K than Ca, and osteoclastic function is necessary to support the enriched levels of surface mineral K in the presence of acidosis.
Bushinsky
D A
DA
Department of Medicine, University of Rochester School of Medicine, New York 14642, U.S.A.
Gavrilov
K
K
Chabala
J M
JM
Featherstone
J D
JD
Levi-Setti
R
R
D000138:Acidosis / Q000503:physiopathology*; D000818:Animals; D000831:Animals, Newborn; D015519:Bone Density; D002116:Calcitonin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D005624:Frontal Bone / Q000378:metabolism / Q000648:ultrastructure; D006863:Hydrogen-Ion Concentration; D007553:Isotope Labeling; D013058:Mass Spectrometry; D051379:Mice; D008855:Microscopy, Electron, Scanning; D009924:Organ Culture Techniques; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D010294:Parietal Bone / Q000378:metabolism / Q000648:ultrastructure; D011188:Potassium / Q000378:metabolism*; D011194:Potassium Isotopes; D012886:Skull / Q000378:metabolism*
D011194:Potassium Isotopes; D002116:Calcitonin; D011188:Potassium; D002118:Calcium